Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China flag China · Delayed Price · Currency is CNY
46.49
+1.46 (3.24%)
Mar 14, 2025, 2:44 PM CST

Jiangsu Hengrui Medicine Company Description

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents.

It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products.

Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.

Jiangsu Hengrui Medicine Co., Ltd.
Country China
Founded 1970
Industry Drug Manufacturers - General
Sector Healthcare
Employees 19,611
CEO Hong Bin Dai

Contact Details

Address:
No. 38, Huanghe Road
Lianyungang City, Liaoning Province 222000
China
Phone 86 40 0828 3900
Website hengrui.com

Stock Details

Ticker Symbol 600276
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE0000014W7
SIC Code 2834

Key Executives

Name Position
Hong Bin Dai GM and Director
Jianjun Liu Financial Director
Jie Ping Sun Deputy GM and Director
Dr. Lian Shan Zhang Ph.D. Deputy GM and Director
Dr. Ningjun Jiang M.D., Ph.D. Deputy GM and Director
Xiao Han Liu Secretary of the Board of Directors
Su Mei Jiang Deputy General Manager
Ya Ping Shen Deputy General Manager
Cheng Liao Deputy General Manager
Hongsen Wang Deputy General Manager